Red Nucleus, a Yardley, PA-based provider of strategic services across research and development, medical affairs, market access, and learning and development, medical affairs, market access, and learning and development, received a majority investment from THL Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to expand operations and its business reach.
Red Nucleus is a global strategic partner with experience across the entire life sciences product life cycle. The company specializes in providing clients with insights and efficiencies to support their journey to improve health outcomes and ultimately the quality of people’s lives. Red Nucleus’ “Red Thread” weaves together a suite of products and services from learning and development, scientific services & advisory, medical and scientific communications, and market access, which leads its life sciences customers to accelerated transformational success.
The company further announced that current CEO Ian Kelly is moving into the role of Chief Relationship Officer, with a focus on strengthening customer engagements, and will also serve as Vice Chairman of the Board of Directors. He will be succeeded as CEO by Mike Menta, who previously led the Consulting and Enterprise Solutions divisions at Syneos Health, a biopharmaceutical solutions organization.
FinSMEs
18/10/2024